Close Menu

A Bit of a Debacle

DecodeMe recently announced that 23andMe customers could migrate their data to the Decode analysis platform for free. However, Peter Aldhous at the New Scientist's Short Sharp Science blog says the platform has given "mangled" analyses. From his 23andMe data, the DecodeMe analysis told Aldhous had a 40 percent risk of developing Alzheimer's disease during his life. However, his own Decode data puts his risk at about 14 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Kaiser Health News reports San Francisco and Alameda counties in California are no longer using Verily Life Sciences' COVID-19 testing program.

The New York Times reports that developers in New York City are increasingly interested in life science spaces.

A UK study has found that antibodies against SARS-CoV-2 may decline over time, Reuters reports.

In PNAS this week: genetic and epigenetic variation in individuals with diabetic kidney disease, spontaneous genetic alterations in Saccharomyces cerevisiae, and more.